Ocular Side Effects Induced by 0.25% Alcaftadine Ophthalmic Solution
作者： Jong Soo Lee , Jong Moon Park , Hyun Kyung Cho , Su Jin Kim , Hyoun Do Huh
DOI: 10.3341/JKOS.2017.58.5.595
关键词: Ophthalmology 、 Alcaftadine Ophthalmic Solution 、 Alcaftadine 、 Medicine
摘要:
sci-hub.se 参考文章(13)
De Gaulle I. Chigbu, Alissa Coyne, Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis. Clinical Ophthalmology. ,vol. 9, pp. 1215- 1225 ,(2015) , 10.2147/OPTH.S63790
John L. Ubels, Effects of Preservative-Free Artificial Tear Solutions on Corneal Epithelial Structure and Function Archives of Ophthalmology. ,vol. 113, pp. 371- 378 ,(1995) , 10.1001/ARCHOPHT.1995.01100030127036
Heidi I. Becker, Anterior Uveitis and Concurrent Allergic Conjunctivitis AssociatedWith Long-term Use of Topical 0.2% Brimonidine Tartrate Archives of Ophthalmology. ,vol. 122, pp. 1063- 1066 ,(2004) , 10.1001/ARCHOPHT.122.7.1063
Christophe Baudouin, Allergic reaction to topical eyedrops Current Opinion in Allergy and Clinical Immunology. ,vol. 5, pp. 459- 463 ,(2005) , 10.1097/01.ALL.0000183112.86181.9E
Dominique Brémond-Gignac, The clinical spectrum of ocular allergy Current Allergy and Asthma Reports. ,vol. 2, pp. 321- 324 ,(2002) , 10.1007/S11882-002-0060-8
Gail Torkildsen, Arthur Shedden, The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis. Current Medical Research and Opinion. ,vol. 27, pp. 623- 631 ,(2011) , 10.1185/03007995.2010.548797
Leonard Bielory, Therapeutic Targets in Allergic Eye Disease Allergy and Asthma Proceedings. ,vol. 22, pp. 25- 28 ,(2001) , 10.2500/108854101778249195
M. R. Gonzalez-Mendiola, A. Garcia Balda, M. Cena Delgado, P. Prieto Montano, D. Gonzalez De Olano, M. Sanchez-Cano, Contact allergy from tobramycin eyedrops Allergy. ,vol. 60, pp. 527- 528 ,(2005) , 10.1111/J.1398-9995.2005.00588.X
Santa Jeremy Ono, Mark B. Abelson, Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. The Journal of Allergy and Clinical Immunology. ,vol. 115, pp. 118- 122 ,(2005) , 10.1016/J.JACI.2004.10.042
Eugene B. McLaurin, Nicholas P. Marsico, Stacey L. Ackerman, Joseph B. Ciolino, Julia M. Williams, Linda Villanueva, David A. Hollander, Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials Advances in Therapy. ,vol. 31, pp. 1059- 1071 ,(2014) , 10.1007/S12325-014-0155-3